在卫生技术评估与卫生经济学中捕捉疫苗接种的价值:国家分析与优先价值概念
本文基于已构建的疫苗接种价值框架,与发达国家专家合作,评估18个价值概念在现有经济学评价指南中的纳入情况,并通过八项标准加权评分排序,识别出近期应优先拓展的三个价值概念:宏观经济收益、社会公平与伦理、卫生系统强化与韧性安全。
要点
- 现有经济学评价指南多纳入付费方视角概念,社会视角概念存在缺口。
- 新型广泛社会效益仅在个案中被考虑,指南与实践存在差异。
- 近期优先概念为宏观经济收益、社会公平与伦理、卫生系统强化与韧性安全。
核心结论
- 经济学评价中对疫苗接种价值的评估存在缺口和不一致,可能导致政策与疫苗可及性差异。
- 识别出的三个优先概念为近期更广泛捕捉疫苗接种价值提供了可行路径。
研究设计与样本
- 与发达国家专家合作,基于已开发的疫苗接种价值概念分类开展国家分析。
- 分类包含18个价值概念,分为传统付费方与社会视角概念及新型广泛社会概念。
主要发现
- 指南审查显示各国之间以及指南与实践之间存在差异。
- 传统付费方视角概念(如个体与社会健康收益、医疗费用)通常被纳入。
- 传统社会视角概念(如家庭/照护者健康与经济收益)存在明显缺口。
- 新型广泛社会效益很少被考虑,且仅在个案中被考虑。
关键数值与推荐
- 专家确定八项与决策和测量可行性相关的标准,经加权后对每个概念评分。
- 根据重要性相对排序和指南缺口,识别出三个优先概念。
- 优先概念一:宏观经济收益(如惠及经济、旅游)。
- 优先概念二:社会公平与伦理(如健康结果公平分配、缩小健康/财务公平差距)。
- 优先概念三:卫生系统强化、韧性与安全(如效率提升、减少中断、增加能力)。
临床怎么用
- 作者认为三个优先概念为近期更广泛捕捉疫苗接种价值提供了可行方法。
- 作者指出未来评估中对这些概念进行稳健测量与估值的方法,将有助于强化用于决策的证据。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A value of vaccination framework for economic evaluation (EE) identified unique value concepts for the broad benefits vaccination provides to individuals, society, healthcare systems and national economies. The objectives of this paper were to work with experts in developed countries to objectively identify three priority concepts to extend current EE. METHODS: The previously developed classification of value concepts in vaccination distinguished 18 concepts, categorised as conventional payer and societal perspective concepts and novel broader societal concepts. Their inclusion in current EE guidelines was assessed. Experts identified eight criteria relevant to decision-making and measurement feasibility, which were weighted and used to score each concept. The relative ranking of concepts by importance and the gaps in guidelines were used to identify three priority concepts on which to focus immediate efforts to extend EE. RESULTS: The EE guidelines review highlighted differences across countries and between guidelines and practice. Conventional payer perspective concepts (e.g., individual and societal health gains and medical costs) were generally included, while gaps were evident for conventional societal perspective concepts (e.g., family/caregiver health and economic gains). Few novel broader societal benefits were considered, and only in ad hoc cases. The top-three concepts for near-term consideration: macroeconomic gains (e.g., benefiting the economy, tourism), social equity and ethics (e.g., equal distribution of health outcomes, reduced health/financial equity gaps) and health systems strengthening, resilience and security (e.g., efficiency gains, reduced disruption, increased capacity). CONCLUSIONS: Gaps, inconsistencies and limited assessment of vaccination value in EE can lead to differences in policy and vaccination access. The three priority concepts identified provide a feasible approach for capturing VoV more broadly in the near-term. Robust methods for measuring and valuing these concepts in future assessments will help strengthen the evidence used to inform decisions, improving access to vaccines that are demonstrably good value for money from society's point of view.
引用
- Postma M, Biundo E, Chicoye A, et al. Capturing the value of vaccination within health technology assessment and health economics: Country analysis and priority value concepts. Vaccine. 2022. PMID: 35597688. doi:10.1016/j.vaccine.2022.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。